DILAX
Price
$16.92
Change
+$0.04 (+0.24%)
Updated
Jul 9 closing price
Net Assets
261.82M
VTISX
Price
$192.00
Change
+$1.02 (+0.53%)
Updated
Jul 9 closing price
Net Assets
650.32B
Interact to see
Advertisement

DILAX vs VTISX

DILAX vs VTISX Comparison Chart in %
View a ticker or compare two or three
VS
DILAX vs. VTISX commentary
Jul 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DILAX is a StrongBuy and VTISX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTISX has more cash in the bank: 650B vs. DILAX (262M). VTISX pays higher dividends than DILAX: VTISX (2.57) vs DILAX (0.82). DILAX was incepted earlier than VTISX: DILAX (20 years) vs VTISX (10 years). DILAX (1.05) is less costly to investors than VTISX (0.05). DILAX is a more actively managed with annual turnover of: 21.00 vs. VTISX (4.00). DILAX has a lower initial minimum investment than VTISX: DILAX (1000) vs VTISX (3000000000). VTISX annual gain was more profitable for investors over the last year : 22.77 vs. DILAX (13.51). VTISX return over 5 years is better than : 34.77 vs. DILAX (27.17).
DILAXVTISXDILAX / VTISX
Total Expense Ratio1.050.052,283%
Annual Report Gross Expense Ratio1.050.052,283%
Fund Existence20 years10 years-
Gain YTD0.95512.0938%
Front Load5%N/A-
Min. Initial Investment100030000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets262M650B0%
Annual Yield % from dividends0.822.5732%
Returns for 1 year13.5122.7759%
Returns for 3 years63.4756.89112%
Returns for 5 years27.1734.7778%
Returns for 10 years94.91104.3391%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCISX2.60N/A
N/A
Franklin Income C
IHOAX23.88N/A
N/A
Hartford International Opportunities A
SMVTX13.98N/A
N/A
Virtus Ceredex Mid-Cap Value Equity I
IUAAX34.18N/A
N/A
VY® Invesco Equity and Income A
VVJEX12.17N/A
N/A
Voya VACS Series MCV Fund